medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2015, Number 3

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2015; 13 (3)

Dermatofibrosarcoma Protuberans: A Review

Molinari L, Luna AM, Ferrario D, Galimberti G, Galimberti R

Language: Spanish
References: 69
Page: 201-213
PDF size: 274.25 Kb.


ABSTRACT

Dermatofibrosarcoma protuberans is the most common cutaneous sarcoma. It is characterized by slow growth, with a low metastatic potential but high rate of local recurrences, due to the high capacity of local invasion. The objective of this study is to review the epidemiology, clinical, histology and immunohistochemistry features, as well as the prognosis and treatment of this rare tumor.


REFERENCES

  1. Llombart, B., Serra-Guillén, C., Monteagudo, C. et al., “Dermatofibrosarcoma protuberans: a comprehensive review and update on diagnosis and management”, Semin Diagn Pathol, 2013, 30: 13-28.

  2. Chaput, B., Filleron, T., Le Guellec, S. et al., “Dermatofibrosarcoma protuberans: Margins reduction using slow-Mohs micrographic surgery. Experience with 35 patients”, Ann Chir Plast Esthet, 2014, http://dx.doi. org/10.1016/j.anplas.2013.11.001.

  3. Boguki, B., Neuhaus, I. y Hurst, E.A., “Dermatofibrosarcoma protuberans: a review of the literature”, Dermatol Surg, 2012, 38 (4): 537-551.

  4. Criscione, V.D. y Weinstock, M.A., “Descriptive epidemiology of dermatofibrosarcoma protuberans in the United States, 1973 to 2002”, J Am Acad Dermatol, 2007, junio, 56: 968-973.

  5. Marini, M.A., Parra, L.S., Cordero, A. et al., “Dermatofibrosarcoma protuberans”, en Marini, M.A., Casas, J.G. y Saponaro, A.E., Tumores cutáneos malignos infrecuentes: sarcomas, Alfaomega, Buenos Aires, 2012, 17-39.

  6. Posso-De los Ríos, C.J., Lara-Corrales, I. y Ho, N., “Dermatofibrosarcoma protuberans in pediatric patients: a report of 17 cases”, J Cutan Med Surg, 2014, 18 (3): 180-185.

  7. Tsai, Y.J., Lin, P.Y., Chew, K.Y. et al., “Dermatofibrosarcoma protuberans in children and adolescents: clinical presentation, histology, treatment and review of the literature”, J Plast Reconstr Aesthet Surg, 2014, doi: 10.1016/j.bjps.2014.05.031.

  8. Saeki, H., Ohmatsu, H., Hoashi, T. et al., “Dermatofibrosarcoma protuberans with col1a1(exon18)-pdgfb(exon 2) fusion transcript”, British Journal of Dermatology, 2003, 148: 1028-1031.

  9. Stamatakos, M., Fyllos, A., Siafogianni, A. et al., “Dermatofibrosarcoma protuberans: a rare entity and review of the literature”, jbuon, 2014, 19 (1): 34-41.

  10. Reddy, K.K., Hanke, C.W. y Tierney, E.P., “Malignancy arising within cutaneous tattoos: a case of dermatofibrosarcoma protuberans and review of the literature”, J Drugs Dermatol, 2011, 10 (8): 837-842.

  11. Martin, L., Piette, F., Blanc, P. et al., “Clinical variants of the preprotuberant stage of dermatofibrosarcoma protuberans”, Br J Dermatol, 2005, 153: 932-936.

  12. Bowne, W.B., Antonescu, C.R., Leung, D.H. et al., “Dermatofibrosarcoma protuberans: a clinicopathologic analysis of patients treated and followed at a single institution”, Cancer, 2000, 88: 2711-2720.

  13. Fiore, M., Miceli, R. y Mussi, C., “Dermatofibrosarcoma protuberans treated at a single institution: a surgical disease with a high cure rate”, J Clin Oncol, 2005, 23: 7669-7675.

  14. Serra-Guillén, C., Llombart, B., Nagore, E. et al., “High immunohistochemical nestin expression is associated with greater deph of infiltration in dermatofibrosarcoma protuberans: a study of 71 cases”, J Cutan Pathol, 2013, 40 (10): 871-878.

  15. Serra-Guillén, C., Sanmartín, O., Llombart, B. et al., “Correlation between preoperative magnetic resonance imaging and surgical margins with modified Mohs for dermatofibrosarcoma protuberans”, Dermatol Surg, 2011, 37: 1638-1645.

  16. Pallure, V., Dupin, N. y Guillot, B., “Surgical treatment of Darier-Ferrand Dermatofibrosarcoma: A systematic review”, Dermatol Surg, 2013, 39: 1417-1433, doi: 10.1111/dsu.12299.

  17. Galimberti, G., Pontón Montaño, A., Kowalczuk, A. et al., “Outcomes in 11 patients with dermatofibrosarcoma protuberans trested with Mohs micrographic surgery”, Int J Dermatol, 2012, 51: 89-93.

  18. Paradisi, A., Abeni, D., Rusciani, A. et al., “Dermatofibrosarcoma protuberans: Wide local excision vs. Mohs micrographic surgery”, Cancer Treatment Reviews, 2008, 34: 728-736.

  19. Hollmig, S.T., Sachdev, R., Cockerell, C.J. et al., “Spindle cell neoplasms encountered in dermatologic surgery: a review”, Dermatol Surg, 2013, 38 (6): 825-850.

  20. Lemm, D., Mügge, L.O., Mentzel, T. et al., “Current treatment options in dermatofibrosarcoma protuberans”, J Cancer Res Clin Oncol, 2009, 135: 653-665.

  21. Kokkinos, C., Sorkin, T. y Powell, B., “To Mohs or not to Mohs”, J Plast Reconstr Aesthet Surg, 2014, 67: 23-26.

  22. Bichakjian, C.K., Olencki, T., Alam, M. et al., “Dermatofibrosarcoma protuberans”, version 1.2014, J Natl Compr Canc Netw, 2014, junio, 12 (6): 863-868.

  23. Hersant, B., May, P., Battistella, M. et al., “Reducing surgical margins in dermatofibrosarcoma protuberans using the pathological analysis technique ‘vertical modified technique’: a 5-year experience”, J Plast Reconstr Aesthet Surg, mayo, 2013, 66 (5): 617-622.

  24. Stojadinovic, A., Karpoff, H.M., Antonescu, C.R. et al., “Dermatofibrosarcoma protuberans of the head and neck”, Ann Surg Oncol, 2000, 7(9): 696-704.

  25. Joucdar, S., Kismoune, H., Boudjemia, F. et al., “Darrier and Ferrand dermatofibrosarcomas retrospective analysis of 81 cases over ten years (1983–1994)”, Ann Chir Plast Esthet, 2001, 46 (2): 134-140.

  26. D’Andrea, F., Vozza, A., Brongo, S. et al., “Dermatofibrosarcoma protuberans: experience with 14 cases”, J Eur Acad Dermatol Venereol, 2001, 15 (5): 427-429.

  27. Khatri, V.P., Galante, J.M., Bold, R.J. et al., “Dermatofibrosarcoma protuberans: reappraisal of wide local excision and impact of inadequate initial treatment”, Ann Surg Oncol, 2003, 10 (9): 1118-1122.

  28. Chang, C.K., Jacobs, I.A. y Salti, G.I., “Outcomes of surgery for dermatofibrosarcoma protuberans”, Eur J Surg Oncol, 2004, 30: 341-345.

  29. DuBay, D., Cimmino, V., Lowe, L. et al., “Low recurrence rate after surgery for dermatofibrosarcoma protuberans: a multidisciplinary approach from a single institution”, Cancer, 2004, 100: 1008-1016.

  30. Behbahani, R., Patenotre, P., Capon, N. et al., “To a margin reduction in the dermatofibrosarcomaprotuberans? Retrospective study of 34 cases”, Ann Chir Plast Esthet, 2005, 50 (3): 179-185.

  31. Monnier, D., Vidal, C., Martin, L. et al., “Dermatofibrosarcoma protuberans: a population-based cancer registry descriptive study of 66 consecutive cases diagnosed between 1982 and 2002”, J Eur Acad Dermatol Venereol, 2006, 20: 1237-1242.

  32. Popov, P., Bohling, T., Asko-Seljavaara, S. et al., “Microscopic margins and results of surgery for dermatofibrosarcoma protuberans”, Plast Reconstr Surg, 2007, 119: 1779-1784.

  33. Chien, C.R., Chang, Y.L., Lin, D.T. et al., “Excellent survival of pediatric dermatofibrosarcoma protuberans in Taiwanese”, Pediatr Surg Int, 2007, 23 (3): 211-214.

  34. Stivala, A., Lombardo, G.A.G., Pompili, G. et al., “Dermatofibrosarcoma protuberans: Our experience of 59 cases”, Oncol Lett, 2012, 4: 1047-1055.

  35. Molinari, L., Galimberti, G., Ferrario, D. et al., “Dermatofibrosarcoma protuberans. Cirugía micrográfica de Mohs vs. cirugía convencional”, Piel, 2011, 26 (10): 532-537.

  36. Breuninger, H. y Schaumburg-Lever, G., “Control of excisional margins by conventional histopathological techniques in the treatment of skin tumours. An alternative to Mohs’ technique”, J Pathol, 1988, 154: 167-171.

  37. Tan, W.P., Barlow, R.J., Robson, A. et al., “Dermatofibrosarcoma protuberans: 35 patients treated with Mohs micrographic surgery using paraffin sections”, Br J Dermatol, 2011; 164: 363-366.

  38. Parker, T.L. y Zitelli, J.A., “Surgical margins for excision of dermatofibrosarcoma protuberans”, J Am Acad Dermatol, 1995, 32: 233-236.

  39. Dawes, K.W. y Hanke, C.W., “Dermatofibrosarcoma protuberans treated with Mohs micrographic surgery: cure rates and surgical margins”, Dermatol Surg, 1996, 22 (6): 530-534.

  40. Clayton, B.D., Leshin, B., Hitchcock, M.G. et al., “Utility of rush paraffinembedded tangential sections in the management of cutaneous neoplasms”, Dermatol Surg, 2000, 26 (7): 671-678.

  41. Snow, S.N., Gordon, E.M., Larson, P.O. et al., “Dermatofibrosarcoma protuberans: a report on 29 patients treated by Mohs micrographic surgery with long-term follow-up and review of the literature”, Cancer, 2004, 101 (1): 28-38.

  42. González, A., Marini, M.A., Cordero, A. et al., “La importancia de la técnica micrográfica de Mohs en el tratamiento del dermatofibrosarcoma protuberans”, Act terap Dermatol, 2008, 31: 22-29.

  43. Yu, W., Tsoukas, M.M., Chapman, S.M. et al., “Surgical treatment for dermatofibrosarcoma protuberans: the Dartmouth experience and literature review”, Ann Plast Surg, 2008, 60 (3): 288-293.

  44. Love, W.E., Keiler, S.A., Tamburro, J.E. et al., “Surgical management of congenital dermatofibrosarcoma protuberans”, J Am Acad Dermatol, 2009, 61 (6): 1014-1023.

  45. Serra-Guillén, C., Llombart, B., Nagore, E. et al., “Positive margins in excised dermatofibrosarcoma protuberans: a study of 58 cases treated with slow- Mohs surgery”, J Eur Acad Dermatol Venereol, 2013, doi: 10.1111/jdv.12235.

  46. Loghdey, S., Varma, S., Rajpara, S.M. et al., “Mohs micrographic surgery for dermatofibrosarcoma protuberans (dfsp): A single centre series of 76 patients treated by frozen section Mohs micrographic surgery with a review of the literature”, J Plast Reconstr Aesthet Surg, 2014, doi: 10.1016/j.bjps.2014.05.021.

  47. Gattoni, M., Tiberio, R., Angeli, L. et al., “Dermatofibrosarcoma protuberans: surgical treatment using the Teubingen technique (31 cases)”, Ann Dermatol Venereol, 2007, 134 (1): 31-34.

  48. Hancox, J.G., Kelley, B. y Greenway, H.T. Jr., “Treatment of dermatofibroma sarcoma protuberans using modified Mohs micrographic surgery: no recurrences and smaller defects”, Dermatol Surg, 2008, 34 (6): 780-784.

  49. McArthur, G.A., Demetri, G.D., Van Oosterom, A. et al., “Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225”, J Clin Oncol, 2005; 23: 866-873.

  50. Rutkowski, P., Przybyl, J. y Switaj, T., “Genetics of rare mesenchymal tumors: Implications for targeted treatment in dfsp, asps, ccs, gctb and pecoma”, Int J Biochem Cell Biol, 2014, doi: 10.1016/j.biocel.2014.03.024.

  51. Maki, R.G., Awan, R.A., Dixon, R.H. et al., “Differential sensitivity to imatinib of 2 patients with metastatic sarcoma arising from dermatofibrosarcoma protuberans”, Int J Cancer, 2002, 100: 623-626.

  52. Rubin, B.P., Schuetze, S.M., Eary, J.F. et al., “Molecular targeting of platelet derived growth factor B by imatinib mesylate in a patient with metastatic dermatofibrosarcoma protuberans”, J Clin Oncol, 2002, 20: 3586-3591.

  53. Mizutani, K., Tamada, Y., Hara, K. et al., “Imatinib mesylate inhibits the growth of metastatic lung lesions in a patient with dermatofibrosarcoma protuberans”, Br J Dermatol, 2004, 151: 235-237.

  54. Price, V.E., Fletcher, J.A., Zielenska, M. et al., “Imatinib mesylate: an attractive alternative in young children with large, surgically challenging dermatofibrosarcoma protuberans”, Pediatr Blood Cancer, 2005, 44: 1-5.

  55. Mehrany, K., Swanson, N., Heinrich, M.C. et al., “Dermatofibrosarcoma protuberans: a partial response to imatinib therapy”, Dermatol Surg, 2006, 32: 456-459.

  56. Savoia, P., Ortoncelli, M., Quaglino, P. et al., “Imatinib mesylate in the treatment of a large unresectable dermatofibrosarcoma protuberans: a case study”, Dermatol Surg, 2006, 32: 1097-1102.

  57. Wright, T. y Petersen, J.E., “Treatment of recurrent dermatofibrosarcoma protuberans with imatinib mesylate, followed by Mohs micrographic surgery”, Dermatol Surg, 2007; 33: 741-744.

  58. Lemm, D., Muegge, L., Hoeffken, K. et al., “Remission with imatinib mesylate treatment in a patient with initially unresectable dermatofibrosarcoma protuberans. A case report”, Oral Maxillofac Surg, 2008, 12: 209-213.

  59. Kamar, F.G., Kairouz, V.F. y Sabri, A.N., “Dermatofibrosarcoma protuberans (dfsp) successfully treated with sorafenib: case report”, Clinical Sarcoma Research, 2013, 3: 1-5.

  60. Sun, L.M., Wang, C.J., Huang, C.C. et al., “Dermatofibrosarcoma protuberans: treatment results of 35 cases”, Radiother Oncol, 2000; 57: 175-181.

  61. Dagan, R., Morris, C.G., Zlotecki, R.A. et al., “Radiotherapy in the treatment of dermatofibrosarcoma protuberans”, Am J Clin Oncol, 2005, 28: 537-539.

  62. Castle, K.O., Guadagnolo, B.A., Tsai, C.J. et al., “Dermatofibrosarcoma protuberans: long term outcomes of 53 patients treated with conservative surgery and radiation therapy”, Int J Radiation Oncol Biol Phys, 2013, 86 (3): 585-590.

  63. Radaelli, S., Stachiotti, S., Casali, P.G. et al., “Emerging therapies for adult soft tissue sarcoma”, Expert Rev Anticancer Ther, 2014, 14 (6): 689-704.

  64. Haas, R.L., Keus, R.B., Loftus, B.M. et al., “The role of radiotherapy in the local management of dermatofibrosarcoma protuberans. Soft tissue Tumours Working Group”, Eur J Cancer, 1997, 33: 1055-1060.

  65. Ballo, M.T., Zagars, G.K., Pisters, P. et al., “The role of radiation therapy in the management of dermatofibrosarcoma protuberans”, Int J Radiat Oncol Biol Phys, 1998, 40: 823-827.

  66. Rutgers, E.J., Kroon, B.B., Albus-Lutter, C.E. et al., “Dermatofibrosarcoma protuberans: treatment and prognosis”, Eur J Surg Oncol, 1992, 18: 241-248.

  67. Liang, A.C., Jambusaria-Pahlajani, A., Karia, P.S. et al., “A systematic review of outcome data for dermatofibrosarcoma protuberans with and without fibrosarcomatous change”, J Am Acad Dermatol, 2014, doi: 10.1016/j.jaad.2014.03.018.

  68. Erderm, O., Wyatt, A.J., Lin, E. et al., “Dermatofibrosarcoma protuberans treated with wide local excision and followed at a cancer hospital: prognostic significance of clinicopathologic variables”, Am J Dermatopsthol, 2012, 34 (1): 24-34.

  69. Kim, M., Huh, C.H., Cho, K.H. et al., “A study on the prognostic value of clinical and surgical features of dermatofibrosarcoma protuberans in Korean patients”, J Eur Acad Dermatol Venereol, 2012, 26 (8): 964-971.




2020     |     www.medigraphic.com